Clinical Trials in Nashville

Showing 5041-5060 of 15,379 trials

SEAM Trial: Sutureless End to End Anastomosis by Magnetic Compression

NCT05046730

The objectives of this study are to determine the safety and effectiveness of the SFM Anastomosis Device when used to create a small bowel anastomosis for patients undergoing ileostomy reversal as compared with a propensity-matched historic control group of patients who underwent ileostomy reversal using a conventional closure technique (sutures or stapler).

Retraction of Ileostomy

GI Windows, Inc.128 participantsStarted Feb 2022

Orlando, Florida, United States • Orlando, Florida, United States • Boston, Massachusetts, United States +11 more locations

COMPLETEDEARLY Phase 1< 1 mile

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

NCT03962647

This is a neoadjuvant study to determine the feasibility and tolerability of 2 weeks of a very low carbohydrate ketogenic diet in combination with letrozole for patients with early stage operable ER+disease.

Estrogen Receptor-positive Breast Cancer

Vanderbilt-Ingram Cancer Center31 participantsStarted Jul 2019

Nashville, Tennessee, United States

SEAM Trial: Sutureless End to End Anastomosis by Magnetic Compression

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Find Trials by Condition in Nashville

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Atrasentan in Patients With IgA Nephropathy

Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM

Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors

Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talofibular Ligament (ATFL) to Treat Lateral Ankle Instability

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)